Aterian, Inc. (NASDAQ:ATER) Short Interest Down 48.7% in January

Aterian, Inc. (NASDAQ:ATERGet Free Report) was the target of a large drop in short interest during the month of January. As of January 15th, there was short interest totaling 148,224 shares, a drop of 48.7% from the December 31st total of 289,004 shares. Based on an average daily volume of 168,587 shares, the short-interest ratio is currently 0.9 days. Currently, 1.8% of the shares of the company are short sold. Currently, 1.8% of the shares of the company are short sold. Based on an average daily volume of 168,587 shares, the short-interest ratio is currently 0.9 days.

Institutional Investors Weigh In On Aterian

A number of large investors have recently bought and sold shares of the stock. Goldman Sachs Group Inc. grew its stake in shares of Aterian by 73.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after buying an additional 9,026 shares during the period. Ground Swell Capital LLC bought a new stake in Aterian during the second quarter worth $58,000. XTX Topco Ltd purchased a new stake in shares of Aterian in the second quarter valued at about $55,000. Citadel Advisors LLC increased its stake in Aterian by 222.0% in the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after buying an additional 22,865 shares during the last quarter. Finally, Susquehanna International Group LLP increased its position in shares of Aterian by 310.2% during the third quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after acquiring an additional 30,637 shares during the last quarter. 7.02% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Aterian in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Aterian has an average rating of “Reduce” and a consensus price target of $4.00.

Read Our Latest Report on ATER

Aterian Trading Down 0.3%

Shares of Aterian stock opened at $0.70 on Friday. Aterian has a 1-year low of $0.64 and a 1-year high of $3.50. The company has a market cap of $7.02 million, a PE ratio of -0.43 and a beta of 0.03. The company has a 50 day moving average of $0.76 and a 200-day moving average of $0.95.

Aterian (NASDAQ:ATERGet Free Report) last released its quarterly earnings data on Thursday, November 13th. The company reported ($0.28) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.63) by $0.35. The business had revenue of $19.02 million during the quarter, compared to analysts’ expectations of $19.88 million. Aterian had a negative net margin of 15.73% and a negative return on equity of 47.45%.

Aterian Company Profile

(Get Free Report)

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.

See Also

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.